← All Sponsors
SPONSOR

St. Olavs Hospital

Total Trials
4
Recruiting
4
Phases
Phase 2

St. Olavs Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Chronic Migraine, Myeloma Multiple, Plasma Cell Leukemia, AL Amyloidosis.

The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — St. Olavs Hospital

How many clinical trials has St. Olavs Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by St. Olavs Hospital, of which 4 are actively recruiting participants. These trials cover conditions including Chronic Migraine, Myeloma Multiple, Plasma Cell Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does St. Olavs Hospital research focus on?
St. Olavs Hospital clinical trials span Chronic Migraine, Myeloma Multiple, Plasma Cell Leukemia, AL Amyloidosis, Breast Neoplasms, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a St. Olavs Hospital clinical trial?
To participate in a St. Olavs Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all St. Olavs Hospital trials with current recruitment status updated daily.

Clinical Trials by St. Olavs Hospital

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology